Alzheimer's Disease (AD)
Neurology
Prevalence
700.0 / 100K
Incidence
120.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| vy7523 | Voyager Therapeutics, Inc. (VYGR) |
Frequently asked questions
How many drugs are in development for Alzheimer's Disease (AD)?
BioSniper tracks 1 drug in development for Alzheimer's Disease (AD) across 1 company.
How many clinical trials target Alzheimer's Disease (AD)?
There are 1 clinical trial targeting Alzheimer's Disease (AD) tracked by BioSniper.
What is the prevalence of Alzheimer's Disease (AD)?
The estimated prevalence of Alzheimer's Disease (AD) is approximately 700.0 per 100,000 population.
Deep-dive into Alzheimer's Disease (AD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis